3'-(Trifluoromethyl)[1,1'-biphenyl]-2-ol, 1g

1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-histidine, 95%, 5g

1,2-dicloroetano, minimo 99%, per sintesi, 2,5 L, confezione in vetro

2,2,2-trifluoro-N-(pyridin-2-ylmethyl)acetamide, 95.0%, 1g

2-Amino-3,5,6-trifluorobenzoic acid, 95+%, 250mg

Ethyl 5-bromoimidazo[1,5-a]pyridine-1-carboxylate, 98%, 500mg

3-(chloromethyl)-1,2,4-oxadiazole-5-carboxamide, 95.0%, 250mg

Ethyl 4-nitrophenyl carbonate, 250mg

5'-(4-Cyanophenyl)-[1,1':3',1''-terphenyl]-4,4''-dicarbonitrile, 97%, 1g

1-(2-Chlorophenethyl)piperazine, 95%, 500mg

2-(5-BROMO-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4-YL)PROPAN-2-OL, 95.0%, 250mg

(S)-Morpholine-3-carboxylic acid, 95.0%, 10g

5-CHLORO-1H-INDAZOL-3-YLAMINE, 95%, 2.5g